Get started
Author

Niyaz Yoosuf

Related Giant Viruses in Distant Locations and Different Habitats: Acanthamoeba polyphaga moumouvirus Represents a Third Lineage of the Mimiviridae That Is Close to the Megavirus Lineage
2012 · Niyaz Yoosuf, Natalya Yutin, et al. · Genome Biology and Evolution · 146
PDF
Evidence of the megavirome in humans
2013 · Philippe Colson, Laura Fancello, et al. · Journal of Clinical Virology · 121
“Marseilleviridae”, a new family of giant viruses infecting amoebae
2012 · Philippe Colson, Isabelle Pagnier, et al. · Archives of Virology · 100
PDF
Identification and transfer of spatial transcriptomics signatures for cancer diagnosis
2020 · Niyaz Yoosuf, José Fernández Navarro, et al. · Breast Cancer Research · 94
PDF
Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis
2021 · Niyaz Yoosuf, Mateusz Maciejewski, et al. · Rheumatology · 70
PDF
African Relapsing Fever Borreliae Genomospecies Revealed by Comparative Genomics
2014 · Haitham Elbir, Laurent Abi-Rached, et al. · Frontiers in Public Health · 34
PDF
Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis
2021 · Ravi K. Sharma, Sanjay V. Boddul, et al. · Scientific Reports · 29
PDF
Draft genome sequences of Terra1 and Terra2 viruses, new members of the family Mimiviridae isolated from soil
2014 · Niyaz Yoosuf, Isabelle Pagnier, et al. · Virology · 29
PDF
Complete genome sequence of Courdo11 virus, a member of the family Mimiviridae
2013 · Niyaz Yoosuf, Isabelle Pagnier, et al. · Virus Genes · 26
Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs
2023 · Åsa K. Hedman, Eitan Winter, et al. · Scientific Reports · 21
PDF
Molecular signature of methotrexate response among rheumatoid arthritis patients
2023 · Boel Brynedal, Niyaz Yoosuf, et al. · Frontiers in Medicine · 14
Identification of proteinase 3 autoreactive CD4+T cells and their T-cell receptor repertoires in antineutrophil cytoplasmic antibody–associated vasculitis
2023 · Ravi Kumar Sharma, Niyaz Yoosuf, et al. · Kidney International · 9
PDF
Proposing the Promiscuous Protein Structures in JNK1 and JNK3 for Virtual Screening in Pursuit of Potential Leads
2020 · Ananthasri Sailapathi, Gopinath Murugan, et al. · ACS Omega · 8
PDF
Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al. · Cancer Research · 3
Supplementary Fig 1 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 5 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 4 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Table 1 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Data from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 3 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 10 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 8 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Anti-TNFR2 antibody BI-1808 induces tumor regression and antitumor T cell immunity through T reg and myeloid cell modulation in patients with solid tumors
2026 · Ingrid Teige, Kristoffer S. Rohrberg, et al. · Clinical Cancer Research
Supplementary Fig 9 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 7 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Works count: 41
Citation count: 704
H-index: 11
I10-index: 11
Year
Topic
Type